Jushi Holdings (JUSHF) Other Non-Current Assets (2021 - 2026)
Jushi Holdings (JUSHF) reported Other Non-Current Assets of $2.1 million for Q1 2026, down 93.12% year-over-year from $30.9 million in Q1 2025, and little changed quarter-over-quarter from $2.1 million in Q4 2025.
Jushi Holdings (JUSHF) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Other Non-Current Assets data on file, last reported at $2.1 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $2.1 million, down 93.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 93.12% YoY), and the FY2025 annual result was $2.1 million, up 16.44% from the prior year.
- Other Non-Current Assets was little changed at $2.1 million in Q1 2026 per JUSHF's latest filing, from $2.1 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $37.3 million in Q2 2023 and troughed at $950000.0 in Q3 2022.
- A 5-year average of $18.4 million and a median of $28.6 million in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets jumped 5279.62% in 2022, then plunged 93.99% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $28.2 million in 2022, then rose by 7.49% to $30.4 million in 2023, then sank by 93.99% to $1.8 million in 2024, then increased by 16.44% to $2.1 million in 2025, then changed by 0.0% to $2.1 million in 2026.
- Business Quant data shows JUSHF's Other Non-Current Assets at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $31.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 31.63 Mn |
| Jun 30, 2025 | 34.27 Mn |
| Mar 31, 2025 | 30.88 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 28.98 Mn |
| Mar 31, 2024 | 30.32 Mn |
| Dec 31, 2023 | 30.36 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 37.27 Mn |
| Mar 31, 2023 | 950,000.00 |
| Dec 31, 2022 | 28.24 Mn |
| Sep 30, 2022 | 950,000.00 |
| Jun 30, 2022 | 30.48 Mn |
| Dec 31, 2021 | 525,000.00 |